How Much Weight Should I Be Losing on Mounjaro?

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has emerged as one of the most effective prescription weight loss medications available. Clinical data shows that people using tirzepatide lose significantly more weight than those on diet and exercise alone—but the rate and total amount vary greatly from person to person.

Average Weekly Weight Loss on Tirzepatide

During the dose-escalation phase (weeks 1–16), most people lose between 1 and 2 pounds per week. This initial loss reflects both fat reduction and the appetite-suppressing effects that tirzepatide triggers in the brain's feeding centers. The medication works by activating two hormone receptors—GLP-1 and GIP—that signal fullness, slow stomach emptying, and improve blood sugar control.

After reaching your maintenance dose, weight loss may continue but often at a slower pace of 0.5 to 1 pound per week. This deceleration is normal and reflects the body's adaptation to the medication. Studies show that people maintain steady progress through months 4–12 and beyond, provided they stick with consistent dosing and lifestyle habits.

Total Weight Loss Over One Year

In the SURMOUNT clinical trials, participants on tirzepatide lost an average of 21–22% of their starting body weight over 68 weeks. For someone weighing 250 pounds, this translates to roughly 52–55 pounds. Notably, some individuals in the trials lost more than 25% of body weight, while others reached 15%—demonstrating the wide range of personal outcomes.

Weight loss typically follows a three-phase pattern: rapid loss in months 1–4, steady loss in months 5–9, and a maintenance plateau by month 10–12. Reaching maximum benefit usually takes 12–16 weeks at your target maintenance dose. The timing and magnitude of your results depend on your genetics, starting weight, adherence to dosing, and lifestyle factors like diet quality and physical activity.

Why Your Weight Loss May Differ from Others

Genetic variation plays a significant role in how your body responds to tirzepatide. Key gene variants—including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—influence your appetite regulation, metabolic rate, and fat storage patterns. PlexusDx's Precision Peptide Genetic Test maps 14 different metabolic pathways and 49 peptides to reveal how your unique genetic blueprint affects weight loss potential.

Beyond genetics, factors like your starting body mass index, age, insulin resistance level, adherence to medication timing, dietary choices, and physical activity intensity all shape your individual results. Someone with significant insulin resistance may see faster initial loss as blood sugar improves. Conversely, a person with lower starting weight may reach a plateau sooner. This is why personalized, precision medicine approaches—like those offered through PlexusDx—help optimize outcomes based on your specific biology rather than population averages.

When to Expect Results and How to Track Progress

Most people notice initial appetite suppression within the first week of starting tirzepatide, though significant weight loss typically appears by week 3–4. Weighing yourself weekly (ideally at the same time and day) provides the clearest picture of your progress. Some people prefer monthly weigh-ins to avoid the psychological stress of daily fluctuations—both approaches are valid as long as you choose one and stick with it consistently.

Progress photos, measurements (waist, hips, chest), and how your clothes fit often reveal changes that the scale misses, especially if you're building muscle through exercise. If you're not seeing expected loss after 8–12 weeks at your maintenance dose, discuss with your healthcare provider whether your dose needs adjustment, lifestyle factors are limiting results, or genetic testing might illuminate personalized optimization strategies. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with no membership fee, and the optional Precision Peptide Genetic Test ($99 after your first month) can guide dose and compound selection to match your genetic profile.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is a realistic first-month weight loss goal on tirzepatide?

Most people lose 4–8 pounds in the first month as their dose ramps up and appetite suppression begins. This early loss includes water weight alongside fat loss. If you see minimal change in month one, this is not unusual—some people experience a delayed response. Consistent results typically compound by month two and three.

Do you lose weight faster on tirzepatide than semaglutide?

Clinical evidence indicates tirzepatide produces greater weight loss than semaglutide at comparable durations. In head-to-head trials, tirzepatide users lost approximately 3–5 pounds more over 12 months. This difference stems from tirzepatide's dual GLP-1 and GIP activity, whereas semaglutide targets only the GLP-1 receptor. PlexusDx offers both medications—tirzepatide injection at $289/mo (or $249/mo on the 6-month plan) and semaglutide starting at $189/month—allowing your provider to match your choice to your goals and genetics.

Will I regain weight if I stop taking tirzepatide?

Research shows that weight often returns after discontinuing tirzepatide, though not always to baseline. Many people maintain 5–10 pounds of their loss through sustained lifestyle changes. Tirzepatide works best as a long-term medication paired with durable dietary and activity habits. PlexusDx patients can continue tirzepatide indefinitely—your dose may need to go up, but your price won't, keeping treatment affordable and accessible.

Is 1 pound per week a safe weight loss rate on tirzepatide?

Yes, 1–2 pounds per week is considered safe and aligns with most weight loss medicine guidelines. Faster loss may lead to muscle loss, nutritional deficiency, or gallstone formation. Slower loss (0.5 lb/week) is also safe and may suit your lifestyle. Your healthcare provider should monitor you regularly to ensure your loss rate is healthy and sustainable.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite, energy expenditure, and fat metabolism. Knowing your genetic profile helps your provider anticipate whether you'll likely respond rapidly, reach a higher total loss, or benefit from dose optimization. This $99 test maps 150+ insights across 14 pathways, empowering truly personalized treatment decisions beyond one-size-fits-all dosing.

Related Reading

• Mounjaro For Losing Weight
• Glp 1 For Losing Weight
• Zepbound For Losing Weight
• Ozempic For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.